Your browser doesn't support javascript.
loading
Use of raloxifene and tamoxifen by breast cancer risk level in a Medicare-eligible cohort.
Pinsky, Paul F; Miller, Eric; Heckman-Stoddard, Brandy; Minasian, Lori.
Afiliação
  • Pinsky PF; Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD. Electronic address: pinskyp@mail.nih.gov.
  • Miller E; Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Heckman-Stoddard B; Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Minasian L; Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Am J Obstet Gynecol ; 218(6): 606.e1-606.e9, 2018 06.
Article em En | MEDLINE | ID: mdl-29630889
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama / Carcinoma / Cloridrato de Raloxifeno / Antagonistas de Estrogênios Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama / Carcinoma / Cloridrato de Raloxifeno / Antagonistas de Estrogênios Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2018 Tipo de documento: Article